financetom
Business
financetom
/
Business
/
Summit, AstraZeneca in talks over $15 billion partnership deal, Bloomberg News reports
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Summit, AstraZeneca in talks over $15 billion partnership deal, Bloomberg News reports
Jul 3, 2025 8:16 AM

July 3 (Reuters) - Summit Therapeutics ( SMMT ) and

AstraZeneca ( AZN ) are discussing a partnership deal worth as

much as $15 billion, Bloomberg News reported on Thursday, citing

people familiar with the matter.

Under the potential deal, AstraZeneca ( AZN ) could license Summit's

experimental lung-cancer treatment, ivonescimab, the report

said.

Summit did not immediately respond to Reuters request

seeking comment, while an AstraZeneca ( AZN ) spokesperson declined to

comment.

A deal between the companies could include an upfront

payment of several billion dollars to Summit and milestone

payments later on, Bloomberg News said.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved